Merck & Co., Inc. has established an Asia R&D headquarters in Beijing, China for innovative drug discovery and development. The new facility is part of the company’s $1.5 billion investment in R&D in China during the next five years. “The establishment of the MSD Asia R&D headquarters represents an important milestone as we implement our strategy of building capabilities, and relationships to succeed in fast growing geographic regions,” said Peter S. Kim, Ph.D., pres...